Here is a quick run down of major issues being discussed by policymakers from an endocrine perspective and the Society’s current advocacy work. Let us know if you would like additional information or have any questions.
What’s Happening in Washington
After finally passing a final FY 2019 appropriations bill, Congress went on a one-week recess. Congress returns February 26 in what will be an exciting week: the Senate Finance Committee will conduct a hearing on Drug Pricing in America to question the CEOs of several major pharmaceutical companies; the Senate Health, Education, Labor, and Pensions (HELP) Committee looks into ways to lower health care costs; and Michael Cohen, President Trump’s personal lawyer, is scheduled to testify before the House Oversight and Reform Committee while the results of the investigation into Russian interference in the 2016 election is expected to be delivered to the Justice Department.
The Endocrine Society is hard at work advocating Congress to increase funding for NIH in FY2020 and reauthorize the Special Diabetes Program before September 30. It is critical that all members of Congress hear from YOU about why these issues are important!
ADVOCACY CAMPAIGN to Support the Special Diabetes Program (SDP) – The SDP, comprised of the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians, is set to expire September 30 unless Congress acts to renew it.Please join our online advocacy campaign urging members of Congress to contact the Speaker and Ranking Republican Leader to schedule action on this important legislation.
RESEARCHER HILL DAY – We are conducting a Researcher Hill Day on February 26 to urge Congress to support increased funding for the National Institutes of Health and endocrine research.Members of the Society from around the country will be joining us to meet with their congressional delegations.If you are not attending Hill Day, you can still help us by contacting your congressional delegation through our online advocacy campaign.The more members who join our campaign, the louder and more influential our voice will be.
DIABETES PREVENTION – We joined the Diabetes Advocacy Alliance in sending a letter to the Centers for Medicare & Medicaid Services on barriers to the implementation of the Medicare Diabetes Prevention Program.